Who is tirpotide suitable for? ——A guide to medication for weight loss vs. diabetes patients

Mounjaro , a GLP-1 + GIP dual agonist , is FDA -approved for the treatment of type 2 diabetes and has demonstrated excellent efficacy in weight management . Compared to traditional GLP-1 receptor agonists (such as semaglutide Wegovy/Ozempic ), Mounjaro not only reduces appetite but also promotes lipolysis and improves insulin sensitivity , making it suitable for a wider range of people.

So, who is suitable to use telpolide? Who is it not recommended for? What are the differences in medication strategies for weight loss versus diabetes?

 

1. Who is suitable for telpoeptide?

① Overweight / obese individuals ( BMI ≥ 30 ) who need to lose weight

•       Goal: To lose weight, reduce visceral fat, and improve overall health.

•       Target audience:

•       Obese patients with a BMI ≥30 (simple obesity).

•       BMI ≥27 but with metabolic abnormalities (such as hyperglycemia, insulin resistance).

•       People who still find it difficult to lose weight after exercising and adjusting their diet.

•       Those who have tried GLP-1 drugs but with poor results (such as Wegovy ).

② Patients with type 2 diabetes (who need to improve blood sugar and weight)

•       Objective: To lower blood sugar, improve insulin sensitivity, and control weight.

•       Target audience:

•       People with HbA1c ≥7.0% who require additional medication to control their blood sugar.

•       Those who have not achieved their blood sugar control target after taking oral hypoglycemic agents (such as metformin).

•       Overweight or obese patients with type 2 diabetes who wish to improve their weight management.

③ People with metabolic syndrome and at risk of hyperglycemia

•       Objective: To prevent diabetes, reduce insulin resistance, and improve cardiovascular health.

•       Target audience:

•       Prediabetes is characterized by high blood sugar or insulin resistance.

•       Individuals with hypertension, hyperlipidemia, and non-alcoholic fatty liver disease ( NAFLD ) .

④ Patients who require long-term weight management

•       Goal: To maintain weight loss results in the long term and reduce the risk of regaining weight.

•       Target audience:

•       People who have failed to lose weight in the past or have repeatedly experienced weight regain.

•       People who need to control their weight in the long term to reduce the risk of chronic diseases (such as those with a family history of diabetes).

💡 Conclusion: Whether for people trying to lose weight, people with diabetes, or people with metabolic disorders, telpoeptide can provide effective weight management and metabolic improvement solutions.

 

2. Weight loss strategies for telpotassium versus medication strategies for diabetic patients.

①Telborpeptide is used for weight loss (for non-diabetic patients).

Target	Primarily targeted at overweight / obese individuals, aiming to reduce weight and body fat percentage.
Starting dose	2.5 mg once a week, gradually increasing to 10-15 mg.
weight loss	Average weight loss after 72 weeks was 22.5% ( SURMOUNT-1 study)
Main mechanisms	Reduces appetite and promotes fat breakdown ( GIP effect)
Long-term effects	Stable weight management, less prone to rebound

 ②Telborpeptide is used for type 2 diabetes.

Target	Primarily used to lower blood sugar and reduce weight.
Starting dose	2.5 mg once a week, gradually increasing to 10-15 mg.
HbA1c decreases	HbA1c decreased by 2.1%–2.3% after 40 weeks ( SURPASS-2 study)
weight loss	Average weight loss of 12% to 15% after 72 weeks (better than other hypoglycemic drugs)
Main mechanisms	Improve insulin sensitivity and reduce glucagon release

💡 Conclusion: The main goal of using telpolide in diabetic patients is to control blood sugar and achieve moderate weight loss , while the main goal in obese patients is to maximize weight loss . Therefore, the dosage adjustment and follow-up strategies are different.

 

3. Who is not suitable to use telpoeptide?

The following groups are not advised to use Mounjaro (Telborpeptide):

❌ Family history of medullary thyroid carcinoma ( MTC ) or MEN 2 patients (due to potential risk of thyroid cancer).

❌ Pregnant women and breastfeeding women (currently, there is a lack of sufficient safety studies).

❌ Patients with severe gastrointestinal diseases (such as severe gastroparesis, chronic gastritis).

❌ Diabetic patients who are using insulin (dosage should be adjusted carefully to avoid the risk of hypoglycemia).

💡 It is recommended to consult a doctor before use to ensure that your individual health condition is suitable for using telpolide.

 

4. Is telpolide an ideal choice for weight loss and diabetes management?

Thiopeptide is suitable for:

✔ Overweight / obese individuals who require significant weight loss (weight reduction of up to 22.5% ).

✔ For patients with type 2 diabetes, it improves blood sugar control and reduces weight.

✔ People with metabolic syndrome and high insulin resistance want to reduce their risk of chronic diseases.

✔ Patients who have not responded well to GLP-1 drugs (such as Wegovy ) in the past.

Advantages of telpoeptide:

✔ The GLP-1 + GIP mechanism reduces appetite and promotes fat breakdown, resulting in better weight loss than Smeglucopyranoside.

✔ Long-term weight management leads to greater stability, a lower risk of weight regain, and milder side effects.

✔ In diabetes management, it has a better blood sugar lowering effect than traditional GLP-1 receptor agonists.

💡 If your goal is efficient and safe weight loss, or to improve diabetes and metabolic health, telpoeptide may be one of the best options available!